Phase 2 N=103 Study of LX6171 in Elderly Volunteers With Age Associated Memory Impairment
Age-Related Memory Disorders
Primary: Number of Participants Who Were Exposed to LX6171 — 35; 33; 31 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=109 Dasatinib (BMS-354825) in Subjects With Myeloid Blast Phase Chronic Myeloid Leukemia Resistant to or Intolerant of Imatinib Mesylate
Chronic Myeloid Leukemia · Blast Crisis
Primary: Major and Overall Hematologic Response (MaHR and OHR) — 2; 34; 36; 4 Participants
Phase 2 N=174 Study of Dasatinib (BMS-354825) in Patients With Accelerated Phase Chronic Myeloid Leukemia
Chronic Myelogenous Leukemia
Primary: Major and Overall Hematologic Response (MaHR and OHR) — 9; 103; 112; 12 participants
Phase 2 N=70 A Placebo-Controlled Trial of St. John's Wort for Irritable Bowel Syndrome
Irritable Bowel Syndrome
Primary: Overall Bowel Symptom Scores (BSS) — 76; 44 Scores on a scale
Phase 2 N=200 The Efficacy and Safety of Phosphatidylserine-Omega3 in Children With Attention-Deficit/ Hyperactivity Disorder
Attention Deficit/Hyperactivity Disorder (ADHD)
Primary: Conners Rating Scale - School Version — -0.44; -1.73; -2.63; -0.63 Scores on a scale
Phase 2 N=39 Fish Oil and Alpha Lipoic Acid in Treating Alzheimer's Disease
Alzheimer's Disease · Oxidative Stress · Dementia
Primary: F2-isoprostane Level Urine F2-Isoprostanes — 0.40; -2.02; 0.45 nanogram per miligram — p=0.83
Phase 2 N=95 PK and Tolerability of IV and Oral CK-1827452 in Patients With Ischemic Cardiomyopathy and Angina
Heart Failure · Myocardial Ischemia · Angina Pectoris
Primary: Participants Stopping Exercise Treadmill Test 3 (ETT-3) for Angina at Stage Earlier Than Baseline Exercise Treadmill Test (ETT-B) — 0; 0; 1 Participants
Phase 2 N=60 Transfusion Strategies in Pediatric Cardiothoracic Surgery
Congenital Heart Disease
Primary: Mean Arterial Lactate Level — 1.4; 1.4 mmol/L
Phase 2 N=111 Open-Label Study Of Exemestane With Or Without Celecoxib In Postmenopausal Women With ABC Having Progressed On Tamoxifen
Breast Neoplasms
Primary: Number of Subjects With Clinical Benefit — 24; 24 participants
Phase 2 N=387 Study of BMS-354825 (Dasatinib) in Patients With Chronic Myeloid Leukemia Who Are Either Resistant or Intolerant to Imatinib
Chronic Myeloid Leukemia · Philadelphia-Positive Myeloid Leukemia
Primary: Number of Imatinib-resistant Participants With Major Cytogenetic Response (MCyR) — 159 Participants
Phase 2 N=55 Study Of SU011248 In Combination With Docetaxel (Taxotere) And Prednisone In Patients With Prostate Cancer
Prostatic Neoplasms
Primary: Percentage of Participants With Prostate Specific Antigen (PSA) Response — 56.4 percentage of participants
Phase 2 N=138 A Clinical Study Of An Investigational Regimen Including Marketed HIV Drugs In HIV-1 Pediatric Subjects Ages 2-18 Years
HIV Infection
Primary: Number of Participants Who Discontinued Treatment Due to Adverse Events — 12; 3; 3; 1 Participants
Phase 2 N=423 Study of Multiple Doses of Saxagliptin (BMS-477118)
Type 2 Diabetes Mellitus
Primary: Analysis of Test for Positive Efficacy Trend in Change From Baseline in Hemoglobin A1c (A1C) at Week 12 in the 0-40 mg Cohort — -0.67; -0.95; -0.81; -0.74 percentage of…
Phase 2 N=242 LifeZig Personalized Reminiscence Video With Slideshows and Music for Individuals With Alzheimer's and Dementia
Alzheimer's Disease · Dementia
Primary: Multidimensional Observation Scale for Elderly Subject — 69.75; 77.99 Units on a scale
Phase 2 N=50 Pioglitazone to Treat Fatty Liver in People With HIV Infection
HIV Infections · Hepatic Steatosis · Insulin Resistance
Primary: Hepatic Steatosis